PTLF (Petlife Pharmaceuticals) Common Stock: $0.08 Mil (As of Feb. 2018)


What is Petlife Pharmaceuticals Common Stock?

Petlife Pharmaceuticals PTLF Common Stock is $0.08 Mil as of Feb. 2018.

Petlife Pharmaceuticals's quarterly common stock stayed the same from Aug. 2017 ($0.07 Mil) to Nov. 2017 ($0.07 Mil) but then increased from Nov. 2017 ($0.07 Mil) to Feb. 2018 ($0.08 Mil).

Petlife Pharmaceuticals's annual common stock declined from Aug. 2015 ($0.01 Mil) to Aug. 2016 ($0.01 Mil) but then increased from Aug. 2016 ($0.01 Mil) to Aug. 2017 ($0.07 Mil).


Petlife Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Common Stock Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.06 0.01 0.01 0.07

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.07 0.07 0.07 0.08

Petlife Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.08 Mil mean?
Petlife Pharmaceuticals (PTLF) has a Common Stock of $0.08 Mil as of Feb. 2018. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Common Stock too high?
Petlife Pharmaceuticals' current Common Stock is $0.08 Mil.
How does Petlife Pharmaceuticals' Common Stock compare to PCYN and YBAO?
Petlife Pharmaceuticals' Common Stock of $0.08 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Petlife Pharmaceuticals and its competitors. Petlife Pharmaceuticals's current Common Stock is $0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Common Stock of $0.08 Mil. The current Common Stock is $0.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Common Stock is $0.08 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.